TREMs Modulate tRNA Pools for Mutant Codon Translation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack effective modulation of tRNA pools in cells to treat or prevent diseases, as they fail to accurately target and adjust the relative amounts of tRNA moieties that pair with specific codons, leading to compromised protein production and function due to SNPs and other genetic variations.

Innovation Solution

The use of tRNA-based effector molecules (TREMs) that pair with specific codons to modulate the tRNA pool by increasing the abundance of isoacceptor tRNAs that correspond to mutant codons, thereby improving protein translation and function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional methods are used to modulate tRNA pools, then general tRNA levels may be increased, but specific tRNA moieties that pair with mutant codons cannot be accurately targeted or adjusted

Engineering Contradiction:
ImprovetRNA pool abundanceVSAvoidspecificity to mutant codons
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent applies local quality by designing TREMs with anticodons specifically matched to mutant codons (e.g.,anticodon 3'‑CCA-5' for codon 5'‑UGG-3'). This enables selective modulation of specific tRNA moieties (e.g., tRNA-Trp) that pair with particular mutant codons, rather than non-specifically increasing all tRNA levels. The specificity is achieved through precise anticodon-codon pairing at the local molecular interaction level.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs parameter changes by modifying the anticodon sequence of TREMs to match specific mutant codons. By changing the anticodon parameter (nucleotide sequence), the TREMs can selectively bind to and modulate specific tRNA moieties corresponding to mutant codons. This allows precise control over which tRNA species are upregulated, addressing the need for specificity in tRNA pool modulation.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If TREMs are designed to pair with specific codons, then translation efficiency for those codons improves, but the complexity of designing and selecting appropriate TREMs increases

Engineering Contradiction:
Improvetranslation efficiencyVSAvoidTREM design complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies universality by using a standardized TREM platform that can be adapted to target any codon-anticodon pair. The core TREM structure and delivery mechanism remain universal, while only the anticodon sequence needs to be customized for each specific mutant codon. This multi-functional approach allows the same platform to address various different codon usage issues across different genes and diseases.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent employs preliminary action by providing a catalog or library of pre-designed TREMs with anticodons matched to common mutant codons. This allows researchers to select appropriate TREMs based on their specific mutant codon without having to design from scratch, thereby reducing the complexity and time required for TREM development while maintaining high translation efficiency.

Inventive Principle:
Principle #10Preliminary action

3Stability of the object's composition

If the abundance of isoacceptor tRNAs is increased to match mutant codons, then protein expression stability improves, but the difficulty of detecting and measuring specific tRNA moiety levels increases

Engineering Contradiction:
Improveprotein expression stabilityVSAvoidspecific tRNA moiety abundance
Core Design Contradiction:
Stability of the object's compositionVSDifficulty of detecting and measuring

Solution Approach 1:

The patent applies the intermediary principle by using TREMs as mediator molecules that can be detected and quantified. The TREMs serve as a measurable proxy for the abundance of specific tRNA moieties, as their levels directly reflect the success of isoacceptor tRNA upregulation. This intermediary approach simplifies measurement compared to directly detecting endogenous tRNA species.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs feedback by establishing methods to measure tRNA pool composition and use this information to guide further TREM administration. By monitoring changes in specific tRNA moiety levels and protein expression outcomes, the dosage and timing of TREM treatment can be adjusted to optimize protein expression stability while maintaining appropriate tRNA abundances.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20220228147A1Uses of TREM compositions to modulate trna pools
Publication Date: 2022.07.21 FLAGSHIP PIONEERING INNOVATIONS VI LLC
  • US20220228147A1 patent drawing
  • US20220228147A1 patent drawing
  • US20220228147A1 patent drawing

AI summary

The invention relates generally to uses of tRNA-based effector molecules (TREMs) and methods of making the same.